Eli Lilly said that it's “not yet in a position to finalize” plans to bring its Gateway Labs to the UK, as it is “awaiting more clarity” on the state of the country’s life sciences industry.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.